Updated:
TriNetX
TriNetX provides trusted, global real‑world health data from academic hospital partners to support research, evidence generation, and informed decisions.
TriNetX
TriNetX provides trusted, global real‑world health data from academic hospital partners to support research, evidence generation, and informed decisions.
General information
Firm type
Corporation
Year founded
2013
Location
Region
North America
Country
United States
City
Cambridge
Corporate office
Cambridge, MA, United States
Additional offices
Sint-Martens-Latem, Belgium · London, United Kingdom · Freiburg, Germany · Pozuelo de Alarcón, Spain · Basel, Switzerland · Tokyo, Japan · Singapore, Singapore · São Paulo, Brazil
Sector focus
Frequently asked questions
Who controls investment decisions at TriNetX?
TriNetX does not disclose its board, executive team, or individual decision-makers on its website. The company’s contact page directs inquiries to general support and RFI/RFP submission forms. No named principals were found in the provided sources.
How does TriNetX generate proprietary data that competitors lack?
TriNetX sources data exclusively through direct partnerships with academic hospital systems — it does not buy or scrape datasets. The data stays within the originating system, preserving provenance, security, and near-real-time currency. This federated model allows traceability to real patient records and enables source-data validation (per the firm’s website).
Is TriNetX structured as a family office or an investment firm?
No. TriNetX is a for-profit corporation providing real-world health data and analytics services to life sciences, healthcare, and academic customers. It does not raise or deploy investment capital as a fund manager.
Does TriNetX accept outside capital or external investors?
TriNetX does not publicly report any fundraising rounds, debt, or equity investors. The company’s ownership structure is not disclosed on its website.
What types of real-world data does the TriNetX platform include?
The platform covers electronic health records, claims, lab results, and genomic data from more than 13,000 clinical sites across 20+ countries (per the firm’s website). Researchers can also access linkable patient data across sources, enabling longitudinal study designs.
What investment stages or deal types does TriNetX avoid?
TriNetX is not an investment firm. It does not make fund commitments, direct investments, or participate in any deal stage.
How is TriNetX related to any parent company or spinout?
TriNetX does not disclose any parent, subsidiary, or spinout relationships on its website beyond its own LLC and subsidiary organizations. The UK Modern Slavery Act statement references TriNetX, LLC and its subsidiaries collectively as 'TriNetX'.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: